ZEPP

Zepp Health Corporation

$2.39

1.70%
SectorTechnologyIndustryConsumer ElectronicsCountryNetherlands

Zepp Health Corporation operates as a smart wearable and health technology company worldwide. It empowers users to live lives by optimizing health, fitness, and wellness journeys through its consumer brands, Amazfit, Zepp Clarity, and Zepp Aura. The company offers smart bands, smart watches, smart rings, hearables, the Helio Strap, smart scales, and accessories; and sportswear, home appliances, and smart watch accessories. It also provides Zepp Aura, a real-time, personalized sound health solution offering health management, including emotional regulation and sports performance optimization; and provides charts and graphs to display analysis of the activity and biometric data collected from users through its Zepp Life and Zepp mobile apps. The company offers its products under the Amazfit and Zepp brand names in approximately 150 countries. The company was formerly known as Huami Corporation and changed its name to Zepp Health Corporation in February 2021.

Source: Yahoo Finance
AI summary

Price & performance

1M-20.0%
3M-34.6%
YTD-87.3%
1Y-93.1%
52-week range—
Beta1.39
Full chart and returns against a benchmark

Q-Score

44/ 100

Quality against peers; 50 is the peer median.

Growth38
Risk38
Performance52
Valuation56
Profitability44
Leverage40
Sentiment—
Every score and metric

News sentiment

Open News

Latest results · FY 2025

Revenue$258.9M+41.8%
Net income-$40.1M
Net margin-15.5%+26.0 pts
Historical fundamentals

Red flags in filings

1active red flag
Material weakness in controlsApr 24, 2026
Filings, findings and the timeline

Revenue exposure

83%of revenue from outside the US
Europe43%
Asia Pacific35%
North America18%
Largest customer10%
Regions, segments, customers and suppliers

Valuation

ZEPPIndustryP/E—37.20P/S0.148.76EV/EBITDA—26.98P/B0.1629.89PEG—1.97
Dividend yield0.00%
Every valuation metric

Earnings

Nov 22next report, after the close
EPS estimate—
Beats (last 4 quarters)—
Average surprise—
EPS revisions (30d)—
Every quarter against its estimate